4.2 Article

Reduced Expression of DNA Repair and Redox Signaling Protein APE1/Ref-1 Impairs Human Pancreatic Cancer Cell Survival, Proliferation, and Cell Cycle Progression

Journal

CANCER INVESTIGATION
Volume 28, Issue 9, Pages 885-895

Publisher

TAYLOR & FRANCIS INC
DOI: 10.3109/07357907.2010.512816

Keywords

Pancreatic cancer; APE1/Ref-1; siRNA; cell cycle

Categories

Funding

  1. NCI NIH HHS [R21 CA122298, R01 CA114571, R01 CA121168-02S1, R01 CA114571-04, R01 CA094025, R01 CA106298-05, R21 CA122298-02, R01 CA094025-05, R01 CA121168, R01 CA106298] Funding Source: Medline

Ask authors/readers for more resources

Pancreatic cancer is a deadly disease that is virtually never cured. Understanding the chemoresistance intrinsic to this cancer will aid in developing new regimens. High expression of APE1/Ref-1, a DNA repair and redox signaling protein, is associated with resistance, poor outcome, and angiogenesis; little is known in pancreatic cancer. Immunostaining of adenocarcinoma shows greater APE1/Ref-1 expression than in normal pancreas tissue. A decrease in APE1/Ref-1 protein levels results in pancreatic cancer cell growth inhibition, increased apoptosis, and altered cell cycle progression. Endogenous cell cycle inhibitors increase when APE1/ Ref-1 is reduced, demonstrating its importance to proliferation and growth of pancreatic cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available